Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126791001 | 12679100 | 1 | I | 20160716 | 20160816 | 20160824 | 20160824 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-068639 | BRISTOL MYERS SQUIBB | 22.74 | YR | F | Y | 0.00000 | 20160824 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126791001 | 12679100 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | ONE OR TWO TABLETS PER DAY | Y | 21436 | TABLET | ||||||||
| 126791001 | 12679100 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 100 MG, UNK | Y | 21436 | 100 | MG | TABLET | ||||||
| 126791001 | 12679100 | 3 | SS | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Unknown | UNK | Y | 0 | FILM-COATED TABLET | ||||||||
| 126791001 | 12679100 | 4 | SS | ATARAX | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Oral | 17 TAB, ONE TIME DOSE | Y | 0 | 17 | DF | FILM-COATED TABLET | ||||||
| 126791001 | 12679100 | 5 | SS | PRAZEPAM | PRAZEPAM | 1 | Unknown | UNK | Y | 0 | TABLET | ||||||||
| 126791001 | 12679100 | 6 | SS | PRAZEPAM | PRAZEPAM | 1 | Oral | 29 TAB, ONE TIME DOSE | Y | 0 | 29 | DF | TABLET | ||||||
| 126791001 | 12679100 | 7 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 50 MG, BID | Y | 0 | 50 | MG | BID | ||||||
| 126791001 | 12679100 | 8 | SS | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | UNK | Y | 0 | |||||||||
| 126791001 | 12679100 | 9 | SS | LEVOCETIRIZINE DIHYDROCHLORIDE. | LEVOCETIRIZINE DIHYDROCHLORIDE | 1 | Unknown | UNK | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126791001 | 12679100 | 1 | Product used for unknown indication |
| 126791001 | 12679100 | 3 | Product used for unknown indication |
| 126791001 | 12679100 | 5 | Product used for unknown indication |
| 126791001 | 12679100 | 7 | Product used for unknown indication |
| 126791001 | 12679100 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126791001 | 12679100 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126791001 | 12679100 | Heart rate decreased | |
| 126791001 | 12679100 | Hypotension | |
| 126791001 | 12679100 | Hypotonia | |
| 126791001 | 12679100 | Overdose | |
| 126791001 | 12679100 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126791001 | 12679100 | 1 | 201512 | 0 | ||
| 126791001 | 12679100 | 2 | 20160716 | 20160716 | 0 | |
| 126791001 | 12679100 | 3 | 201512 | 0 | ||
| 126791001 | 12679100 | 4 | 20160716 | 20160716 | 0 | |
| 126791001 | 12679100 | 5 | 201512 | 0 | ||
| 126791001 | 12679100 | 6 | 20160716 | 20160716 | 0 | |
| 126791001 | 12679100 | 7 | 201512 | 0 | ||
| 126791001 | 12679100 | 8 | 20160716 | 20160716 | 0 | |
| 126791001 | 12679100 | 9 | 20160716 | 20160716 | 0 |